Cargando…
LC-MS/MS Determination of Isoprostanes in Plasma Samples Collected from Mice Exposed to Doxorubicin or Tert-Butyl Hydroperoxide
Isoprostanes are stable products of arachidonic acid peroxidation and are regarded as the most reliable markers of oxidative stress in vivo. Here we describe the LC-MS/MS procedure enabling simultaneous determination of four regioisomers (8-iso prostaglandin F(2α), 8-iso-15(R)-prostaglandin F(2α), 1...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634494/ https://www.ncbi.nlm.nih.gov/pubmed/23507752 http://dx.doi.org/10.3390/ijms14036157 |
_version_ | 1782267116646301696 |
---|---|
author | Janicka, Monika Kot-Wasik, Agata Paradziej-Łukowicz, Jolanta Sularz-Peszyńska, Grażyna Bartoszek, Agnieszka Namieśnik, Jacek |
author_facet | Janicka, Monika Kot-Wasik, Agata Paradziej-Łukowicz, Jolanta Sularz-Peszyńska, Grażyna Bartoszek, Agnieszka Namieśnik, Jacek |
author_sort | Janicka, Monika |
collection | PubMed |
description | Isoprostanes are stable products of arachidonic acid peroxidation and are regarded as the most reliable markers of oxidative stress in vivo. Here we describe the LC-MS/MS procedure enabling simultaneous determination of four regioisomers (8-iso prostaglandin F(2α), 8-iso-15(R)-prostaglandin F(2α), 11β-prostaglandin F(2α), 15(R)-prostaglandin F(2α)) in plasma samples collected from mice. The four plasma isoprostanes are determined by LC–ESI-MS/MS with deuterated 8-iso-PGF(2α)-d(4) as an internal standard (I.S.). For plasma samples spiked with the isoprostanes at a level of 200 pg/mL each, the method imprecision has been below 7.1% and mean inaccuracy equaled 8.7%. The applicability of the proposed approach has been verified by the assessment of changes in isoprostane levels in plasma samples derived from mice exposed to tert-butyl hydroperoxide (TBHP), a model inducer of oxidative stress, or to antitumor drug doxorubicin (DOX) known for potent stimulation of redox cycling. Compared to the control group of mice, both oxidative stress inducers tested increased the levels of three out of four isoprostanes in exposed animals; 11β-prostaglandin F(2α) being the exception. The greatest rise was observed in the case of 15(R)-prostaglandin F(2α), by about 50% and 70% in plasma samples derived from mice exposed to DOX and TBHP, respectively. |
format | Online Article Text |
id | pubmed-3634494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Molecular Diversity Preservation International (MDPI) |
record_format | MEDLINE/PubMed |
spelling | pubmed-36344942013-05-02 LC-MS/MS Determination of Isoprostanes in Plasma Samples Collected from Mice Exposed to Doxorubicin or Tert-Butyl Hydroperoxide Janicka, Monika Kot-Wasik, Agata Paradziej-Łukowicz, Jolanta Sularz-Peszyńska, Grażyna Bartoszek, Agnieszka Namieśnik, Jacek Int J Mol Sci Article Isoprostanes are stable products of arachidonic acid peroxidation and are regarded as the most reliable markers of oxidative stress in vivo. Here we describe the LC-MS/MS procedure enabling simultaneous determination of four regioisomers (8-iso prostaglandin F(2α), 8-iso-15(R)-prostaglandin F(2α), 11β-prostaglandin F(2α), 15(R)-prostaglandin F(2α)) in plasma samples collected from mice. The four plasma isoprostanes are determined by LC–ESI-MS/MS with deuterated 8-iso-PGF(2α)-d(4) as an internal standard (I.S.). For plasma samples spiked with the isoprostanes at a level of 200 pg/mL each, the method imprecision has been below 7.1% and mean inaccuracy equaled 8.7%. The applicability of the proposed approach has been verified by the assessment of changes in isoprostane levels in plasma samples derived from mice exposed to tert-butyl hydroperoxide (TBHP), a model inducer of oxidative stress, or to antitumor drug doxorubicin (DOX) known for potent stimulation of redox cycling. Compared to the control group of mice, both oxidative stress inducers tested increased the levels of three out of four isoprostanes in exposed animals; 11β-prostaglandin F(2α) being the exception. The greatest rise was observed in the case of 15(R)-prostaglandin F(2α), by about 50% and 70% in plasma samples derived from mice exposed to DOX and TBHP, respectively. Molecular Diversity Preservation International (MDPI) 2013-03-18 /pmc/articles/PMC3634494/ /pubmed/23507752 http://dx.doi.org/10.3390/ijms14036157 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Janicka, Monika Kot-Wasik, Agata Paradziej-Łukowicz, Jolanta Sularz-Peszyńska, Grażyna Bartoszek, Agnieszka Namieśnik, Jacek LC-MS/MS Determination of Isoprostanes in Plasma Samples Collected from Mice Exposed to Doxorubicin or Tert-Butyl Hydroperoxide |
title | LC-MS/MS Determination of Isoprostanes in Plasma Samples Collected from Mice Exposed to Doxorubicin or Tert-Butyl Hydroperoxide |
title_full | LC-MS/MS Determination of Isoprostanes in Plasma Samples Collected from Mice Exposed to Doxorubicin or Tert-Butyl Hydroperoxide |
title_fullStr | LC-MS/MS Determination of Isoprostanes in Plasma Samples Collected from Mice Exposed to Doxorubicin or Tert-Butyl Hydroperoxide |
title_full_unstemmed | LC-MS/MS Determination of Isoprostanes in Plasma Samples Collected from Mice Exposed to Doxorubicin or Tert-Butyl Hydroperoxide |
title_short | LC-MS/MS Determination of Isoprostanes in Plasma Samples Collected from Mice Exposed to Doxorubicin or Tert-Butyl Hydroperoxide |
title_sort | lc-ms/ms determination of isoprostanes in plasma samples collected from mice exposed to doxorubicin or tert-butyl hydroperoxide |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634494/ https://www.ncbi.nlm.nih.gov/pubmed/23507752 http://dx.doi.org/10.3390/ijms14036157 |
work_keys_str_mv | AT janickamonika lcmsmsdeterminationofisoprostanesinplasmasamplescollectedfrommiceexposedtodoxorubicinortertbutylhydroperoxide AT kotwasikagata lcmsmsdeterminationofisoprostanesinplasmasamplescollectedfrommiceexposedtodoxorubicinortertbutylhydroperoxide AT paradziejłukowiczjolanta lcmsmsdeterminationofisoprostanesinplasmasamplescollectedfrommiceexposedtodoxorubicinortertbutylhydroperoxide AT sularzpeszynskagrazyna lcmsmsdeterminationofisoprostanesinplasmasamplescollectedfrommiceexposedtodoxorubicinortertbutylhydroperoxide AT bartoszekagnieszka lcmsmsdeterminationofisoprostanesinplasmasamplescollectedfrommiceexposedtodoxorubicinortertbutylhydroperoxide AT namiesnikjacek lcmsmsdeterminationofisoprostanesinplasmasamplescollectedfrommiceexposedtodoxorubicinortertbutylhydroperoxide |